NEW YORK, Feb. 12 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. , a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced that the Company will attend the Roth Capital Partners 19th Annual OC Investor Conference on February 20, 2007 at the Ritz Carlton in Laguna Niguel, CA. Management is currently scheduled to present at 2:30 pm PT. Listeners may access a live webcast of the presentation by visiting the Roth Capital webcast link at http://www.wsw.com/webcast/roth9/aob/.
Investors who would like more information about attending the Roth Capital OC Investor Conference should contact their Roth Capital Partners sales representative.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. (AOB) is engaged in the development and production of plant -based pharmaceutical products and plant-based nutraceutical products widely distributed throughout China. For more information, visit http://www.bioaobo.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
American Oriental Bioengineering, Inc.CONTACT: Ashley Ammon, or Bill Zima, Integrated Corporate Relations, Inc.,+1-203-682-8200
